Clinical Trial
Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease
- PMID: 12857569
Item in Clipboard
Clinical Trial
Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease
Haematologica.
2003 Jul.
No abstract available
Comment in
-
Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD).Haematologica. 2003 Aug;88(8):ELT28; author reply ELT29. Haematologica. 2003. PMID: 12935991 No abstract available.
Similar articles
-
Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD).Haematologica. 2003 Aug;88(8):ELT28; author reply ELT29. Haematologica. 2003. PMID: 12935991 No abstract available.
-
Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens.Bone Marrow Transplant. 2006 Jan;37(2):235-6; author reply 236-7. doi: 10.1038/sj.bmt.1705227. Bone Marrow Transplant. 2006. PMID: 16284607 No abstract available.
-
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7. Transplant Proc. 1998. PMID: 9865306 Clinical Trial. No abstract available.
-
The use of mycophenolate mofetil in liver transplant recipients.Expert Opin Pharmacother. 2003 Nov;4(11):1949-57. doi: 10.1517/14656566.4.11.1949. Expert Opin Pharmacother. 2003. PMID: 14596648 Review.
-
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.Ann N Y Acad Sci. 2001 Jun;938:328-37; discussion 337-9. Ann N Y Acad Sci. 2001. PMID: 11458521 Review.
Cited by
-
Treatment of chronic graft-versus-host disease: Past, present and future.Korean J Hematol. 2011 Sep;46(3):153-63. doi: 10.5045/kjh.2011.46.3.153. Epub 2011 Sep 30. Korean J Hematol. 2011. PMID: 22065969 Free PMC article.
-
Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.Int J Hematol. 2012 Jul;96(1):10-25. doi: 10.1007/s12185-012-1086-x. Epub 2012 May 17. Int J Hematol. 2012. PMID: 22592321 Review.
-
[Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):265-275. doi: 10.3760/cma.j.issn.0253-2727.2021.04.001. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33979969 Free PMC article. Chinese. No abstract available.
-
[Chinese expert consensus on the diagnosis and treatment of chronic graft-versus-host disease (2024)].Zhonghua Xue Ye Xue Za Zhi. 2024 Aug 14;45(8):713-726. doi: 10.3760/cma.j.cn121090-20240611-00217. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39307718 Free PMC article. Chinese.
-
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.Bone Marrow Transplant. 2019 May;54(5):662-673. doi: 10.1038/s41409-018-0340-0. Epub 2018 Dec 7. Bone Marrow Transplant. 2019. PMID: 30531954